openPR Logo
Press release

MAG 7 Undercard: $5 Stocks to Watch - NDRA, BSLK, WOLF, OCC, SNYR Poised for Action More Inside

07-08-2025 07:26 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

MAG 7 Undercard: $5 Stocks to Watch - NDRA, BSLK, WOLF, OCC, SNYR

Investor interest builds in speculative micro-cap names under the radar of Wall Street's "Magnificent Seven" ENDRA

Life Sciences (NASDAQ: NDRA) is advancing its flagship TAEUS Registered ultrasound system for non-invasive liver diagnostics. With clinical trials in progress and plans for a De Novo FDA submission, NDRA's latest financial report showed improved cash management and narrowing losses. Trading just below $3.50, the company remains on biotech radars as a speculative play in the fight against metabolic liver disease.

Bolt Projects Holdings (NASDAQ: BSLK) is exploring a new identity through a pivot into sustainable biomaterials, including its proprietary "vegan silk" applications for beauty and health products. Formerly a SPAC, the company's transition is being closely watched following its Q1 2025 financial release and reverse split earlier this year. Trading near $2.50, BSLK is attracting renewed attention amid talks of a potential acquisition strategy.

Wolfspeed Inc. (NYSE: WOLF) While no longer strictly a sub-$5 stock, WOLF earns its spot in the undercard lineup for its strategic importance in the silicon carbide semiconductor space. With demand surging from electric vehicles and high-power electronics, Wolfspeed is expanding capacity and capturing institutional interest despite short-term price fluctuations. Its presence anchors the list with long-term tech potential.

Optical Cable Corporation (NASDAQ: OCC) a low-float telecom infrastructure play, is regaining attention as broadband investment ramps up under U.S. infrastructure programs. The company, trading around the $4-6 range, has exposure to data center connectivity, defense communications, and fiber-optic growth markets. Investors are eyeing this name as a sleeper bet on infrastructure-backed digital expansion.

Synergy CHC Corp. (NASDAQ: SNYR) Best known for its FOCUSfactor Registered brain health supplements and energy drink line, SNYR is executing a nationwide retail push with listings in Walmart (NYSE: WMT), Amazon (NASDAQ: AMZN), and Costco (NASDAQ: COST). With former Coca-Cola (NYSE: KO) executives joining the beverage division and Bloomberg TV exposure underway, SNYR is positioning for breakout visibility. Shares recently saw increased volume on distribution expansion news.

Other Micro-Caps Gaining Traction: Keep an eye on names like Power Metallic Mines (OTCQB: PNPNF | TSXV: PNPN), Health In Tech Inc. (NASDAQ: HIT) and Peraso Inc (NASDAQ: PRSO) all making aggressive early trading moves this week.

The Undercard Opportunity

While these stocks lack the trillion-dollar valuations of the market's mega caps, their low share prices and high-beta profiles make them ripe for breakout moves. For traders and speculative investors, this undercard group offers diverse exposure across biotech, tech, materials, and consumer wellness-all at sub-$5 price points.

The StreetWatch: While tech giants dominate headlines, a group of undercard small-caps trading under $5 are capturing attention with bold moves, sector catalysts, and speculative momentum. This "MAG 7 Undercard" lineup includes ENDRA Life Sciences (NASDAQ: NDRA), Bolt Projects Holdings (NASDAQ: BSLK), Wolfspeed Inc. (NYSE: WOLF), Optical Cable Corporation (NASDAQ: OCC), and Synergy CHC Corp. (NASDAQ: SNYR). These companies, each operating in high-impact sectors from biomaterials to semiconductors, are gaining ground on investor watchlists.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=mag-7-undercard-5-stocks-to-watch-ndra-bslk-wolf-occ-snyr-poised-for-action-more-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release MAG 7 Undercard: $5 Stocks to Watch - NDRA, BSLK, WOLF, OCC, SNYR Poised for Action More Inside here

News-ID: 4096562 • Views:

More Releases from ABNewswire

Starry Venus Submits Album SOUL for Grammy Registered Consideration, Marking a Defining Moment in Her Artistic Journey
Starry Venus Submits Album SOUL for Grammy Registered Consideration, Marking a D …
Sedona, AZ - Visionary artist Starry Venus has officially submitted her album SOUL for Grammy Registered consideration, a milestone that underscores her growing influence as a boundary-pushing voice in today's music scene. Known for her ethereal soundscapes and empowering lyrical narratives, Starry Venus captivates audiences with music that blends artistry, spirituality, and authenticity. The submitted album, SOUL, showcases Starry Venus's ability to fuse raw emotion with expansive sound design across multiple
Non-Hodgkin Lymphoma Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | AstraZeneca, Baxter, Bayer, Bristol Myers Squibb, Teva Pharma, Eli Lilly, Roche
Non-Hodgkin Lymphoma Pipeline 2025: Detailed Clinical Trials and FDA-Approved Th …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Non-Hodgkin Lymphoma pipeline constitutes 200+ key companies continuously working towards developing 220 + Non-Hodgkin Lymphoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Non-Hodgkin Lymphoma Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/non-hodgkins-lymphoma-nhl-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Non-Hodgkin Lymphoma Market. The Non-Hodgkin Lymphoma Pipeline
Viltrox Showcases Upcoming Lens Lineup and New TTL Flash at IBC 2025
Viltrox Showcases Upcoming Lens Lineup and New TTL Flash at IBC 2025
Discover Viltrox Innovations at IBC 2025 - Hall 11, Booth A09, RAI Amsterdam, September 12-15 Shenzhen, China - September 10th, 2025 - Viltrox, a leading innovator in photographic and cine optics, will unveil a diverse portfolio of upcoming products at IBC 2025. Visitors can discover the brand's latest advances in lens and imaging technology, including new autofocus lenses, a next-generation TTL flash, and intelligent optical solutions designed to enhance creative workflows. Product
Get the Cheapest Billy Strings 2025 Tour Tickets Online with Promo Code CITY10 - Best Price Online at CapitalCityTickets.com
Get the Cheapest Billy Strings 2025 Tour Tickets Online with Promo Code CITY10 - …
Score the cheapest Billy Strings 2025 tour tickets online with promo code CITY10. Get the best prices, secure your seats fast, and enjoy an unforgettable live performance. CapitalCityTickets.com offers easy online purchase and unbeatable deals for all seating levels. Don't wait-grab your tickets today and experience Billy Strings live without breaking the bank. Are you ready to witness the electrifying bluegrass performances of Grammy-winning artist Billy Strings on his 2025 tour?

All 5 Releases


More Releases for NASDAQ:

Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release. Financials Mischaracterized, Says Peraso Peraso rebuffed Mobix's
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders
Investigation announced for Investors in NASDAQ: MTTR over possible Wrongdoing a …
An investigation was announced for investors in shares of Matterport, Inc. (NASDAQ: MTTR) was announced over potential breaches of fiduciary duties by certain officers and directors at Matterport, Inc. Investors who purchased shares of Matterport, Inc. (NASDAQ: MTTR) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Matterport, Inc. directors breached their fiduciary duties and